NASDAQ: NOVT

Novanta (NOVT) Stock Analysis & Forecast

Nov 13 close

$118.88+1.46 (+1.2%)

Gekko Brief

AI summaryNov 9 close

Novanta reported third quarter 2026 financial results on 9 November, following a preview that flagged analysts expecting 21.5% year-on-year revenue growth after a prior quarter in which both EBITDA and revenue guidance topped forecasts. Ahead of the print, a liquidity mapping analysis from Stock Traders Daily described strong sentiment across all horizons and an overweight bias on the stock. At the last reported quarter, 5 August, Novanta posted adjusted EPS of $0.89 against a $0.83 estimate, with a 2.4% reaction, part of a stretch of 5 beats in the last 8 quarters.

Shares closed at $145.98, up 8% on the day, sitting between the 50-day average of $142.25 and the 200-day average of $142.48. One-year return stands at 36.1%, though the three-month return is -13%. The GekkoIndex reads 57.6, placing the stock in the Neutral zone, up 2.4 over five days. Price sits 6.4% above Gekko Fair Value of $137.21.

No confirmed next earnings date appears on the calendar. Smart-money data shows no insider, Congress or unusual options activity in their respective 90-day and 30-day windows, and there are 0 trailblazer holders. Seasonally, the next 20 trading days have averaged +5.6% over 5 years, rising in 3 of them. The sole covering analyst holds a buy rating with a consensus target of $194.50, implying 33.2% upside from current levels.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Novanta price vs fair value

$129.89$118.88Nov ’25May ’26Nov ’26
Close $118.88200-day averageGekko Fair Value $129.89

Novanta quick facts

Market cap
$4.50B
P/E ratio
87.9
Forward P/E
8.4
EPS, TTM
$1.32
Revenue, TTM
$1.09B
Profit margin
4.9%
Dividend yield
—
Beta
1.70
Volume
606,605 avg 522,265
1-year return
+7.7%
Typical daily move
±7.5%
Typical 20-day move
±6.4%
50-day average
$140.29
200-day average
$142.12
Next earnings
Feb 22
Shares outstanding
37.82M
52-week range
$98.27$176.38

Novanta swing-trade checklist

Novanta scores 4 supportive, 0 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive0 mixed1 headwind

  • Trendheadwind

    Below 50 and 200-day

    Close $118.88 is below the 50-day ($140.29) and 200-day ($142.12) averages, and the 50-day is below the 200-day.

    See the chart
  • GekkoIndexsupportive

    68.9, Accumulation

    Reading 68.9 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    8.5% below

    Price is 8.5% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 99 days

    Next report Feb 22, 2027, 99 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +6.4% on average

    From this point in the calendar, the next 20 trading days averaged +6.4% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Novanta stock chart and price history

Novanta closed at $118.88 on Nov 13, 2026, +7.7% over the past year, inside a 52-week range of $98.27 to $176.38.

Close50-day average200-day averageVolume
Novanta share price, past year, with 50-day and 200-day moving averages and volume$100$140$160DecJan 2026FebMarAprMayJunJulAugSepOctNov118.88

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−11.8%
3 months
−29.6%
6 months
−22.3%
1 year
+7.7%
The full NOVT chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open NOVT in Gekko

Follow Novanta through every session

Put NOVT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track NOVT in GekkoFree for 7 days. No credit card required.

About Novanta

Novanta designs and manufactures engineered components used inside larger equipment made by other manufacturers, with a focus on photonics, vision, and precision motion technology. Its parts and sub-assemblies serve original equipment manufacturers in the medical and industrial fields, and the company is recognized for building the specialized building blocks that go into imaging, laser, and motion-control equipment rather than selling finished products directly to end users.

The business is arranged into three segments. The photonics group makes laser-based systems, including scanning and beam-steering tools and several laser types, used in manufacturing, measurement, medical imaging, and applications like DNA sequencing. The vision group supplies medical instruments such as insufflators and pumps, visualization and wireless communication tools for operating rooms, plus machine vision, RFID, and spectrometry equipment. The precision motion group provides encoders, motors, servo drives, motion control systems, robotic end-effectors, and air bearings. Novanta reaches customers through a direct sales force along with resellers, distributors, and system integrators, and sells under a number of established brand names.

The company began in 1968 and previously operated as GSI Group before adopting the Novanta name in May 2016. It is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ under the ticker NOVT.

Listed
NASDAQ
Sector
Electronic technology
Industry
Electronic equipment/Instruments
Website
novanta.com

Novanta GekkoIndex: the smart money zone

Novanta’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 68.9, in the Accumulation zone, up 6.4 points over five sessions.

010068.9Accumulation

Up 6.4 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying27+3.2%+3.2%+7.7%+3.8%
Accumulation (current zone)272+0.2%+1.1%+0.4%+1.2%
Neutral385−0.3%−0.5%−0.5%−1.4%
Distribution17+0.2%−4.5%−4.1%−4.0%
Selling1Too few readings yet

Average NOVT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the NOVT price, zone by zone.Track NOVT in Gekko

Is Novanta stock overvalued? Gekko Fair Value

Novanta trades 8.5% below Gekko Fair Value of $129.89, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Novanta shares are worth, recalculated every trading day.

$129.89

Gekko Fair Value, Nov 14, 2026

8.5% Undervalued

At the end of Aug 2026 the price was 16.5% above the estimate.

Gekko Fair ValueShare price, month end
$130$119Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open NOVT in Gekko

Novanta insider and Congress trading

No open-market insider purchases were filed for Novanta, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for NOVT in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every NOVT insider filing, plotted on the chart in Gekko.Open NOVT in Gekko

Congress trades last 90 days

No trades in NOVT were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for NOVT, plotted on the chart in Gekko.Open NOVT in Gekko

Buybacks

Novanta has been buying back its own shares.

Bought back, quarter ended Jul 3, 2026
$18.64M
As a share of market cap
0.41%
Trailing four quarters
$70.69M

From company filings.

Hedge funds and billionaires quarter ended Jun 30

0of the funds Gekko tracks hold NOVT.

0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Novanta earnings: next date and track record

Novanta reports on Feb 22, 2027 (99 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±6.4%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

+8.0%Feb ’25−0.9%May ’25−8.3%Aug ’25+1.8%Nov ’25−5.8%Feb ’26+15.1%May ’26+2.4%Aug ’26−8.5%Nov ’26

Last earnings call, Nov 9, 2026 AI summary

What they said
Novanta reported Q3 2026 revenue of $305 million, up 23% reported and 10% organically, the strongest organic growth in over 3 years. Adjusted EBITDA grew 38% to $80 million (26% margin, a record and +290bps YoY). Adjusted EPS rose 21% to $1.05. The company closed its largest-ever acquisition, Riverpoint Medical. Book-to-bill was 1.08 with backlog of $543 million; YTD operating cash flow of $156 million is nearly 3x prior year.
Guidance
Management expects medical end markets to approach 60% of revenue on a full-year basis including Riverpoint. Robotics and automation growth momentum is expected to sustain into 2027, and precision manufacturing innovation pipeline is set to ramp in 2027.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 9, 2026$1.05
est $0.97
+8.6%$305.0M
est $301.0M
+1.3%−8.5%
Aug 5, 2026$0.89
est $0.83
+7.2%$265.8M
est $262.3M
+1.3%+2.4%
May 11, 2026$0.51
est $0.83
−38.2%$257.7M
est $253.4M
+1.7%+15.1%
Feb 23, 2026$0.91
est $0.91
+0.4%$258.3M
est $255.6M
+1.1%−5.8%
Nov 3, 2025$0.87
est $0.84
+3.6%$247.8M
est $255.6M
−3.0%+1.8%
Aug 5, 2025$0.76
est $0.74
+2.7%$241.0M
est $248.5M
−3.0%−8.3%
May 6, 2025$0.59
est $0.67
−12.8%$233.4M
est $240.7M
−3.1%−0.9%
Feb 25, 2025$0.76
est $0.71
+6.5%$238.1M
est $244.6M
−2.7%+8.0%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Novanta stock forecast and analyst price targets

Analysts’ average 12-month price target for Novanta is $185.00, +55.6% from the last close, from 2 firms rating the stock in the last 90 days.

$185.00consensus 12-month target, +55.6% from the last close
Buy2
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 2 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 12Robert W. BairdBuy, maintained$175+47.2%
Oct 5William BlairBuy, maintained——
+0.4%average 20-day move after past Accumulation readings
+6.4%average move over the next 20 trading days in the last 5 years
±7.5%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Novanta seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Novanta averaged +6.4% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

+1.6%2021−1.7%2022+18.6%2023−2.1%2024+15.0%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+1.5%3 of 5
Next 10 trading days+1.2%2 of 5
Next 15 trading days+3.9%3 of 5
Next 20 trading days+6.4%3 of 5
Next 30 trading days+5.7%3 of 5

For scale, NOVT’s typical 20-trading-day move in either direction is about 6.4%.

Novanta market cap and key statistics

Novanta’s market cap is $4.50B, with a P/E ratio of 87.9 and revenue of $1.09B over the last twelve months.

Valuation

Market cap
$4.50B
P/E ratio
87.9
Forward P/E
8.4
EPS, TTM
$1.32
Gekko Fair Value
$129.89

Trading

Volume
606,605
Avg volume, 20 days
522,265
52-week high
$176.38
52-week low
$98.27
Shares outstanding
37.82M

Financials

Revenue, TTM
$1.09B
Profit margin
4.9%
Return on equity
4.4%
Quarterly earnings growth, YoY
−84.0%

Risk and income

Beta
1.70
Typical daily move
±7.5%
Typical 20-day move
±6.4%

Novanta stock news this week

Coverage of Novanta this week reads positive: 2 positive, 2 neutral and 0 negative headlines.

News sentiment positive

Novanta peers

Novanta’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
EMREmerson Electric−0.6%Neutral16.5% above
KEYSKeysight Technologies−2.1%Accumulation3.4% below
QQnity Electronics−2.4%Neutral4.7% below
FTVFortive−0.6%Neutral15.1% above
NXTNextpower+1.2%Neutral3.0% below
NVMINova−2.0%Neutral4.2% above

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Electronic equipment/Instruments

Novanta stock FAQ

What is Novanta’s market cap?

Novanta’s market cap is $4.50B at the Nov 13, 2026 close of $118.88, with 37.82M shares outstanding. The shares trade on a P/E ratio of 87.9.

What is the Novanta stock forecast?

The consensus analyst 12-month price target for Novanta is $185.00, +55.6% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Novanta stock overvalued or undervalued?

On Gekko’s estimate Novanta is undervalued: the Nov 13, 2026 close of $118.88 is 8.5% below Gekko Fair Value of $129.89. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Novanta report earnings next?

Novanta is expected to report on Feb 22, 2027 (99 days away). Analysts expect earnings of $0.96 per share on revenue of $309.7M. Novanta beat the earnings estimate in 6 of its last 8 reports, moving 6.4% on average across the report.

What is Novanta’s 52-week high and low?

Novanta’s 52-week high is $176.38 and its 52-week low is $98.27; it closed at $118.88 on Nov 13, 2026, +7.7% over the past year. Over the last five years the shares peaked at $187.61 on Jun 30, 2023.

Is Novanta stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Novanta the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.